XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Understand the tax consequences associated with cash back rewards. Be informed to maximize your financial benefits.
23,321 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Affluent homeowners are shaping the remodeling outlook as 2026 approaches. Aging housing stock and increased equity b...
New real estate investors often hit a wall when income is inconsistent. DSCR loans offer a financing strategy grounde...
Tether has taken a stake in Whop, with the platform moving to deploy its WDK for on-chain payouts in USDT and USAT. T...
The stock market live february narrative took a turn as Nvidia’s earnings digest kept major averages flat, with SPY h...
In 2025, holdings' 2025 review: from fintech disruptor to banking powerhouse marks a turning point from rapid scale t...
A top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
Policy shifts around AI chips could change how Nvidia and AMD ship GPUs worldwide. This article breaks down the risks...
Bitcoin’s leverage ratio drops on major venues amid rising risk-off mood, as analysts watch whether spot buying retur...
Oil prices rose as the IEA deployed an historic stock draw, yet Carlyle Group’s Currie argued there’s policy response...
IBM stock slides as Anthropic's AI code tool threatens IBM's COBOL modernization business, forcing investors to repri...
The S&P 500 nudges higher as Brent crude hovers above $103, lifting energy names. Analysts flag the biggest things dr...